Adherence in Acute Coronary Syndrome

Video

Jeffrey Berger, MD, discusses how research can help increase adherence to therapies among acute coronary syndrome patients.

In this video, from AJMCtv, Jeffrey Berger, MD, assistant professor at NYU Langone Medical Center, discusses how research can help increase adherence to therapies among acute coronary syndrome (ACS) patients.

Recent Videos
Image credit: Gorodenkoff | stock.adobe.com
Pharmacist and Patient in Pharmacy | Image Credit: Gorodenkoff - stock.adobe.com
Sun Screen, Photosensitivity, Pharmacy | Image Credit: sosiukin - stock.adobe.com
Catalyst Trial, Diabetes, Hypertension | Image Credit: grinny - stock.adobe.com
Image Credit: © Anastasiia - stock.adobe.com
Related Content
Pregnant woman -- Image credit: Syda Productions | stock.adobe.com

Analysis Findings Indicate Relationship Between Maternal Asthma and Risk for Autism Spectrum Disorders

Gillian McGovern, Assistant Editor
July 24th 2024
Article
Pharmacy Focus: What to Know About Medication and Summer Travel

Pharmacy Focus: What to Know About Medication and Summer Travel

July 12th 2024
Podcast
Image Credit: © Africa Studio - stock.adobe.com

FDA Approves IncobotulinumtoxinA for the Simultaneous Treatment of Upper Facial Lines

Alexandra Gerlach, Associate Editor
July 24th 2024
Article
Pharmacy Focus: Oncology Edition- Benefits of Subcutaneous Amivantamab for Lung Cancer Treatment

Pharmacy Focus: Oncology Edition- Benefits of Subcutaneous Amivantamab for Lung Cancer Treatment

June 27th 2024
Podcast
Man and woman hiking in Infected ticks forest with warning sign. Risk of tick-borne and lyme disease - Image credit: 24K-Production | stock.adobe.com

During Summer Months, Counsel Patients on Preventing Lyme Disease

Sofiya Volynsky, PharmD;Atosa Nazemi, PharmD;Melissa Russo, PharmD;Bruce Roberts, PharmD;Mandy Hoysan, PharmD
July 24th 2024
Article
Medicine law concept. Judges gavel with pills - Image credit: Iren Moroz | stock.adobe.com

The Ethics and Economics of California’s End of Life Option Act

Sawyer Y. Mustopoh;Joseph L. Fink III, JD, BSPharm, DSc (Hon), FAPhA
July 24th 2024
Article